by Steve Adams | Nov 11, 2022
A speculative Burlington development that shifted from office to lab-ready space in 2019 was sold to MetLife Investment Management for $103 million after three life science companies leased the entire building early this year.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Special offer for new subscribers –
try B&T online for just $9.99 for your first month!
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.
